RO-0335 is a potent diphenylether NNRTI with sub-nanomolar activity against wild-type HIV-1 (IC50 = 1.1 nM). It demonstrates broad efficacy, maintaining activity (IC50 < 100 nM) against 92% of NNRTI-resistant clinical isolates in virological assays, supporting its use in antiretroviral resistance research.